Two Wall Street firms moved on Microsoft's stock Monday, with Melius Research upgrading the NASDAQ-listed shares to Buy and setting a $665 price target, while Scotiabank lifted its own target to $615. Both calls landed on October 5, 2026, and both point to the same underlying equity that trades under the MSFT ticker.
The near-simultaneous notes put fresh attention on a stock that's already a core holding for plenty of portfolios, and they come as a tokenized version of Microsoft — a blockchain-based contract tracking the share price — pushes toward a technical level that traders have been watching.
What the two calls actually said
Melius went further than Scotiabank by changing its rating, not just its target. An upgrade to Buy signals the firm now expects the shares to outperform, and $665 is its stated objective. Scotiabank kept its rating unchanged but moved its target up to $615, meaning it sees less upside than Melius does from the current price.
The gap between the two targets isn't huge — $50 — but it's a reminder that price targets are estimates, not promises. Both figures are tied to the NASDAQ-listed Microsoft equity, so they refer to the same instrument. Neither note included a detailed public rationale in the facts available, and neither firm issued a quoted statement about the timing.
The tokenized contract and the $541 line
Separately, a tokenized Microsoft contract is closing in on resistance at $541. That token isn't the stock itself — it's a digital contract designed to mirror the share's price — but its chart is drawing its own kind of attention. Resistance is the level where sellers have previously stepped in and pushed the price back down. If the token clears $541, it would mark a break above that ceiling; if it stalls there, the level holds.
What makes the two stories intersect is the direction of travel. Analyst upgrades and raised targets can feed momentum into related instruments, including tokenized versions. But a token trading near resistance is also a spot where the move can fail. There's no guarantee the analyst notes push the token through $541, and there's no guarantee they don't.
Why two targets matter more than one
Single-firm notes are easy to dismiss. Two firms moving on the same day is harder to ignore, especially when one is an upgrade and the other is a target raise. It suggests the bullish case isn't isolated to one research desk.
That said, the targets sit below where Melius sees the stock going and above where Scotiabank does. Investors who track these numbers will notice the spread and draw their own conclusions. The market's actual reaction — on both the NASDAQ-listed shares and the tokenized contract — is the part that can't be scripted in advance.
What to watch from here
The $541 resistance on the tokenized Microsoft contract is the nearest concrete marker. A close above it would confirm the breakout; repeated rejections would suggest the level is still in control. On the equity side, the two new targets give traders a fresh set of reference points to measure against.
There's no scheduled date in the facts for when the token might test $541 again, and no earnings or product event listed that would force the issue. For now, the setup is simple: two analyst moves on the same day, one tokenized contract, and a price level that hasn't been cleared yet.
